

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.32086740 |
| 2 | central nervous system myelination (GO:0022010) | 6.32086740 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.10190983 |
| 4 | sodium ion export (GO:0071436) | 5.68425383 |
| 5 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.49217892 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.47622266 |
| 7 | cellular potassium ion homeostasis (GO:0030007) | 5.27925980 |
| 8 | glutamate secretion (GO:0014047) | 5.21091187 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.15438103 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 5.15438103 |
| 11 | fatty acid elongation (GO:0030497) | 5.07974563 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.85447734 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.83047258 |
| 14 | cell communication by electrical coupling (GO:0010644) | 4.79607931 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.74609360 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.74609360 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.38755833 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.38358903 |
| 19 | amyloid precursor protein metabolic process (GO:0042982) | 4.34542278 |
| 20 | cell communication involved in cardiac conduction (GO:0086065) | 4.31940312 |
| 21 | neuronal ion channel clustering (GO:0045161) | 4.29858396 |
| 22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.28488723 |
| 23 | intestinal cholesterol absorption (GO:0030299) | 4.19604662 |
| 24 | positive regulation of synapse maturation (GO:0090129) | 4.19245373 |
| 25 | response to methylmercury (GO:0051597) | 4.01751665 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.92346960 |
| 27 | potassium ion homeostasis (GO:0055075) | 3.90635579 |
| 28 | cellular sodium ion homeostasis (GO:0006883) | 3.84712690 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.83636660 |
| 30 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.78190902 |
| 31 | regulation of lipoprotein metabolic process (GO:0050746) | 3.77778953 |
| 32 | potassium ion import (GO:0010107) | 3.76568934 |
| 33 | locomotory exploration behavior (GO:0035641) | 3.73128121 |
| 34 | aromatic amino acid family catabolic process (GO:0009074) | 3.72140736 |
| 35 | cerebellar granule cell differentiation (GO:0021707) | 3.68290499 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.66073642 |
| 37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.65774067 |
| 38 | ensheathment of neurons (GO:0007272) | 3.65629152 |
| 39 | axon ensheathment (GO:0008366) | 3.65629152 |
| 40 | cholesterol biosynthetic process (GO:0006695) | 3.64556927 |
| 41 | myelination (GO:0042552) | 3.60365298 |
| 42 | amyloid precursor protein catabolic process (GO:0042987) | 3.57399107 |
| 43 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.54388927 |
| 44 | L-amino acid import (GO:0043092) | 3.53846395 |
| 45 | cofactor catabolic process (GO:0051187) | 3.49019234 |
| 46 | coenzyme catabolic process (GO:0009109) | 3.48544705 |
| 47 | very long-chain fatty acid metabolic process (GO:0000038) | 3.48098629 |
| 48 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.46274559 |
| 49 | neuromuscular process controlling balance (GO:0050885) | 3.45990236 |
| 50 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.44897360 |
| 51 | creatine metabolic process (GO:0006600) | 3.43093136 |
| 52 | myelin maintenance (GO:0043217) | 3.42668467 |
| 53 | vocalization behavior (GO:0071625) | 3.42239047 |
| 54 | heme transport (GO:0015886) | 3.42047004 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 3.41469697 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 3.40697261 |
| 57 | virion attachment to host cell (GO:0019062) | 3.40697261 |
| 58 | regulation of synapse maturation (GO:0090128) | 3.35928200 |
| 59 | cholesterol efflux (GO:0033344) | 3.35848290 |
| 60 | postsynaptic membrane organization (GO:0001941) | 3.34273395 |
| 61 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.33999140 |
| 62 | alpha-linolenic acid metabolic process (GO:0036109) | 3.32562818 |
| 63 | sterol biosynthetic process (GO:0016126) | 3.30256422 |
| 64 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28889333 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.25754023 |
| 66 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.24309363 |
| 67 | neurotransmitter transport (GO:0006836) | 3.23250773 |
| 68 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.22332198 |
| 69 | response to lipoprotein particle (GO:0055094) | 3.21975631 |
| 70 | bile acid biosynthetic process (GO:0006699) | 3.21652094 |
| 71 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.21383084 |
| 72 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.17141250 |
| 73 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.16969322 |
| 74 | glyoxylate metabolic process (GO:0046487) | 3.16675670 |
| 75 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.16029006 |
| 76 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.15571573 |
| 77 | cardiac muscle contraction (GO:0060048) | 3.13583685 |
| 78 | activation of protein kinase A activity (GO:0034199) | 3.12600699 |
| 79 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.12369871 |
| 80 | neuronal action potential propagation (GO:0019227) | 3.10978884 |
| 81 | regulation of cell communication by electrical coupling (GO:0010649) | 3.08520217 |
| 82 | cysteine metabolic process (GO:0006534) | 3.08497032 |
| 83 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.08444780 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.03812870 |
| 85 | regulation of triglyceride catabolic process (GO:0010896) | 3.03806036 |
| 86 | protein carboxylation (GO:0018214) | 3.03586386 |
| 87 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.03586386 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.03181380 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.03181380 |
| 90 | regulation of synapse structural plasticity (GO:0051823) | 3.00873846 |
| 91 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.00838847 |
| 92 | positive regulation of dendritic spine development (GO:0060999) | 2.99698785 |
| 93 | detection of calcium ion (GO:0005513) | 2.99499143 |
| 94 | regulation of ARF protein signal transduction (GO:0032012) | 2.97614430 |
| 95 | adhesion of symbiont to host (GO:0044406) | 2.96780290 |
| 96 | tyrosine metabolic process (GO:0006570) | 2.96095167 |
| 97 | regulation of collateral sprouting (GO:0048670) | 2.95995665 |
| 98 | regulation of neurotransmitter levels (GO:0001505) | 2.95736905 |
| 99 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.94675343 |
| 100 | regulation of synaptic plasticity (GO:0048167) | 2.93660586 |
| 101 | intestinal absorption (GO:0050892) | 2.93606033 |
| 102 | cholesterol metabolic process (GO:0008203) | 2.93033118 |
| 103 | cholesterol homeostasis (GO:0042632) | 2.92695180 |
| 104 | bile acid metabolic process (GO:0008206) | 2.92457263 |
| 105 | sterol homeostasis (GO:0055092) | 2.91573821 |
| 106 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90001727 |
| 107 | sulfur amino acid catabolic process (GO:0000098) | 2.89077856 |
| 108 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.88612250 |
| 109 | regulation of cholesterol esterification (GO:0010872) | 2.88439556 |
| 110 | neurotransmitter uptake (GO:0001504) | 2.87896400 |
| 111 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.87721276 |
| 112 | glycosylceramide metabolic process (GO:0006677) | 2.87209610 |
| 113 | positive regulation of membrane potential (GO:0045838) | 2.85671572 |
| 114 | protein-lipid complex assembly (GO:0065005) | 2.85575419 |
| 115 | exploration behavior (GO:0035640) | 2.84975862 |
| 116 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84260096 |
| 117 | acidic amino acid transport (GO:0015800) | 2.81969948 |
| 118 | glutathione derivative metabolic process (GO:1901685) | 2.81777110 |
| 119 | glutathione derivative biosynthetic process (GO:1901687) | 2.81777110 |
| 120 | regulation of actin filament-based movement (GO:1903115) | 2.81214199 |
| 121 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.80271010 |
| 122 | iron coordination entity transport (GO:1901678) | 2.79666865 |
| 123 | cardiac conduction (GO:0061337) | 2.76794130 |
| 124 | import into cell (GO:0098657) | 2.74350095 |
| 125 | high-density lipoprotein particle remodeling (GO:0034375) | 2.74072622 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72526829 |
| 127 | sterol metabolic process (GO:0016125) | 2.71026730 |
| 128 | neutrophil activation involved in immune response (GO:0002283) | 2.70972009 |
| 129 | plasma lipoprotein particle assembly (GO:0034377) | 2.70625536 |
| 130 | layer formation in cerebral cortex (GO:0021819) | 2.70264683 |
| 131 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.70239088 |
| 132 | phosphate ion transmembrane transport (GO:0035435) | 2.69619939 |
| 133 | synaptic vesicle endocytosis (GO:0048488) | 2.67269537 |
| 134 | gamma-aminobutyric acid transport (GO:0015812) | 2.64956452 |
| 135 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.64757349 |
| 136 | isoprenoid biosynthetic process (GO:0008299) | 2.63850670 |
| 137 | aromatic amino acid family metabolic process (GO:0009072) | 2.63353148 |
| 138 | protein localization to endosome (GO:0036010) | 2.62892850 |
| 139 | positive regulation of sodium ion transport (GO:0010765) | 2.61735721 |
| 140 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.61625854 |
| 141 | positive regulation of dendrite development (GO:1900006) | 2.61392250 |
| 142 | low-density lipoprotein particle clearance (GO:0034383) | 2.60220886 |
| 143 | glutamate metabolic process (GO:0006536) | 2.60007896 |
| 144 | sterol transport (GO:0015918) | 2.59728216 |
| 145 | cholesterol transport (GO:0030301) | 2.59728216 |
| 146 | acyl-CoA biosynthetic process (GO:0071616) | 2.57959340 |
| 147 | thioester biosynthetic process (GO:0035384) | 2.57959340 |
| 148 | amino acid import (GO:0043090) | 2.57832667 |
| 149 | lipoprotein transport (GO:0042953) | 2.57138121 |
| 150 | macroautophagy (GO:0016236) | 2.56775273 |
| 151 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.56766380 |
| 152 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.54770814 |
| 153 | drug transmembrane transport (GO:0006855) | 2.54443966 |
| 154 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.53995060 |
| 155 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.52118606 |
| 156 | peripheral nervous system axon ensheathment (GO:0032292) | 2.52118389 |
| 157 | myelination in peripheral nervous system (GO:0022011) | 2.52118389 |
| 158 | L-glutamate transport (GO:0015813) | 2.51835807 |
| 159 | regulation of neurotransmitter secretion (GO:0046928) | 2.51762341 |
| 160 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.51633258 |
| 161 | negative regulation of cholesterol transport (GO:0032375) | 2.51309162 |
| 162 | negative regulation of sterol transport (GO:0032372) | 2.51309162 |
| 163 | neuromuscular process controlling posture (GO:0050884) | 2.51286979 |
| 164 | regulation of cholesterol metabolic process (GO:0090181) | 2.51273464 |
| 165 | astrocyte development (GO:0014002) | 2.50855903 |
| 166 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.49970757 |
| 167 | long-term memory (GO:0007616) | 2.49718099 |
| 168 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.49707668 |
| 169 | response to mercury ion (GO:0046689) | 2.49369095 |
| 170 | cell volume homeostasis (GO:0006884) | 2.48557375 |
| 171 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.48298127 |
| 172 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.48023439 |
| 173 | flavonoid metabolic process (GO:0009812) | 2.46909693 |
| 174 | ethanol metabolic process (GO:0006067) | 2.46566388 |
| 175 | urea cycle (GO:0000050) | 2.46383363 |
| 176 | urea metabolic process (GO:0019627) | 2.46383363 |
| 177 | protein-lipid complex remodeling (GO:0034368) | 2.45967881 |
| 178 | macromolecular complex remodeling (GO:0034367) | 2.45967881 |
| 179 | plasma lipoprotein particle remodeling (GO:0034369) | 2.45967881 |
| 180 | kynurenine metabolic process (GO:0070189) | 2.45959809 |
| 181 | regulation of dendritic spine development (GO:0060998) | 2.45360315 |
| 182 | substantia nigra development (GO:0021762) | 2.44868349 |
| 183 | ethanol oxidation (GO:0006069) | 2.44680019 |
| 184 | reverse cholesterol transport (GO:0043691) | 2.44448662 |
| 185 | dicarboxylic acid transport (GO:0006835) | 2.42999004 |
| 186 | negative regulation of lipase activity (GO:0060192) | 2.42456670 |
| 187 | dendritic spine organization (GO:0097061) | 2.41659034 |
| 188 | cellular modified amino acid catabolic process (GO:0042219) | 2.40552999 |
| 189 | cellular response to catecholamine stimulus (GO:0071870) | 2.40132020 |
| 190 | cellular response to monoamine stimulus (GO:0071868) | 2.40132020 |
| 191 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.39756961 |
| 192 | sodium ion homeostasis (GO:0055078) | 2.38994414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.18164452 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.13846208 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68367400 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.34135331 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.20762187 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.99196959 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.91705880 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85780673 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.84763121 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62231999 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44659170 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.38913661 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18703143 |
| 14 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.14601321 |
| 15 | KDM2B_26808549_Chip-Seq_K562_Human | 2.12025045 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.11721269 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.10197645 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08986270 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06800946 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.06325128 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.06325128 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.03270185 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01924635 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.98290848 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98146099 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95092564 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.92319606 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90663061 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.90004678 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85669548 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.84118620 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83257872 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.82644379 |
| 34 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80056387 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.78784850 |
| 36 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.77317770 |
| 37 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.72890132 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71332915 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70848138 |
| 40 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.66127684 |
| 41 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.65922377 |
| 42 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.64271061 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62958237 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.62655697 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62546176 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.61532857 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.60876208 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.60876208 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60168102 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59171314 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57317270 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56197728 |
| 53 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.52544347 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.52007198 |
| 55 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50804067 |
| 56 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.50554460 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49310367 |
| 58 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49270608 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46958949 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45789864 |
| 61 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40653921 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40161820 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37916508 |
| 64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.37871683 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36489362 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.36020512 |
| 67 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.35517074 |
| 68 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.34812707 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34051236 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33368870 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31481885 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29805507 |
| 73 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29234929 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28986767 |
| 75 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28570103 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28240438 |
| 77 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27267804 |
| 78 | P68_20966046_ChIP-Seq_HELA_Human | 1.26849486 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25071468 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24827007 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24548479 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24163034 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24041040 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.22929405 |
| 85 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22612432 |
| 86 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.22459138 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20684564 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20510986 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16310337 |
| 90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12505075 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11250894 |
| 92 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.10497064 |
| 93 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09381824 |
| 94 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09381824 |
| 95 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08450300 |
| 96 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08201169 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07527452 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07438005 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06426312 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06376566 |
| 101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04761296 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04595143 |
| 103 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04104838 |
| 104 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.03708080 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03438482 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03424280 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02838639 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02479297 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02356529 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02200177 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01729375 |
| 112 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00907526 |
| 113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00507750 |
| 114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00416707 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00410509 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00005712 |
| 117 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.99086322 |
| 118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98781600 |
| 119 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98612093 |
| 120 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96662640 |
| 121 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96472539 |
| 122 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96454423 |
| 123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96258324 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95671028 |
| 125 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.94490901 |
| 126 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94354423 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94130515 |
| 128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93769835 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93455860 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91843195 |
| 131 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90202477 |
| 132 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89761259 |
| 133 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89755311 |
| 134 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88892892 |
| 135 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88867007 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88777404 |
| 137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88615773 |
| 138 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88560705 |
| 139 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87819647 |
| 140 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87296529 |
| 141 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87224454 |
| 142 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86534417 |
| 143 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86493709 |
| 144 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86293343 |
| 145 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86080004 |
| 146 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84552290 |
| 147 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82959178 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82320462 |
| 149 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82022384 |
| 150 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.80582073 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80457143 |
| 152 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80250422 |
| 153 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.80039017 |
| 154 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79499226 |
| 155 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.78995934 |
| 156 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78572729 |
| 157 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77320017 |
| 158 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76541080 |
| 159 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76161423 |
| 160 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.74529301 |
| 161 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74176639 |
| 162 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.74077710 |
| 163 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.73843239 |
| 164 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72744272 |
| 165 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.72374672 |
| 166 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72066816 |
| 167 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71925805 |
| 168 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71591598 |
| 169 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70735207 |
| 170 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70726285 |
| 171 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.70612839 |
| 172 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.70045018 |
| 173 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70014387 |
| 174 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68549917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.46116530 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.32723612 |
| 3 | MP0005360_urolithiasis | 5.25318814 |
| 4 | MP0009840_abnormal_foam_cell | 4.02885596 |
| 5 | MP0005058_abnormal_lysosome_morphology | 4.02768738 |
| 6 | MP0003880_abnormal_central_pattern | 3.66146325 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.51810482 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.51101682 |
| 9 | MP0000920_abnormal_myelination | 3.48723396 |
| 10 | MP0003690_abnormal_glial_cell | 3.42144660 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 3.40330717 |
| 12 | MP0003195_calcinosis | 3.24069299 |
| 13 | MP0005365_abnormal_bile_salt | 3.19232193 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 3.14782635 |
| 15 | MP0001666_abnormal_nutrient_absorption | 3.03121438 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.96899455 |
| 17 | MP0005083_abnormal_biliary_tract | 2.80959717 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.76666686 |
| 19 | MP0008569_lethality_at_weaning | 2.71915357 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.52595562 |
| 21 | MP0002272_abnormal_nervous_system | 2.42925690 |
| 22 | MP0003879_abnormal_hair_cell | 2.40280737 |
| 23 | MP0009745_abnormal_behavioral_response | 2.39712560 |
| 24 | MP0000604_amyloidosis | 2.35661332 |
| 25 | MP0006082_CNS_inflammation | 2.24138005 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.23286290 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.21191420 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.20280222 |
| 29 | MP0003252_abnormal_bile_duct | 2.19998392 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 2.18342052 |
| 31 | MP0000751_myopathy | 2.12670964 |
| 32 | MP0000566_synostosis | 2.10238132 |
| 33 | MP0005332_abnormal_amino_acid | 2.01548272 |
| 34 | MP0005670_abnormal_white_adipose | 1.99691572 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.98712280 |
| 36 | MP0003329_amyloid_beta_deposits | 1.95154482 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.86040225 |
| 38 | MP0000579_abnormal_nail_morphology | 1.77408325 |
| 39 | MP0009046_muscle_twitch | 1.72128663 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.65573298 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.64994514 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.64671335 |
| 43 | MP0003123_paternal_imprinting | 1.64238071 |
| 44 | MP0004084_abnormal_cardiac_muscle | 1.62201363 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.59242399 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.54316400 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.52790151 |
| 48 | MP0003868_abnormal_feces_composition | 1.51074261 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.50840916 |
| 50 | MP0003634_abnormal_glial_cell | 1.50117628 |
| 51 | MP0004043_abnormal_pH_regulation | 1.48954217 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.43962128 |
| 53 | MP0005451_abnormal_body_composition | 1.42763822 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41131115 |
| 55 | MP0004019_abnormal_vitamin_homeostasis | 1.41059745 |
| 56 | MP0001970_abnormal_pain_threshold | 1.39552906 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.29538051 |
| 58 | MP0003137_abnormal_impulse_conducting | 1.28556929 |
| 59 | MP0004510_myositis | 1.28267529 |
| 60 | MP0005646_abnormal_pituitary_gland | 1.25890989 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.22330402 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.20017215 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.19324490 |
| 64 | MP0004742_abnormal_vestibular_system | 1.19073887 |
| 65 | MP0000609_abnormal_liver_physiology | 1.18289494 |
| 66 | MP0003632_abnormal_nervous_system | 1.18233802 |
| 67 | MP0003122_maternal_imprinting | 1.18164484 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.17302668 |
| 69 | MP0004036_abnormal_muscle_relaxation | 1.16140748 |
| 70 | MP0005257_abnormal_intraocular_pressure | 1.15101537 |
| 71 | MP0002067_abnormal_sensory_capabilities | 1.13217054 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 1.12557696 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.11884198 |
| 74 | MP0000778_abnormal_nervous_system | 1.11636626 |
| 75 | MP0002557_abnormal_social/conspecific_i | 1.10873170 |
| 76 | MP0003300_gastrointestinal_ulcer | 1.10764464 |
| 77 | MP0002736_abnormal_nociception_after | 1.09492302 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.09084111 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.09040832 |
| 80 | MP0002419_abnormal_innate_immunity | 1.08643259 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.06967649 |
| 82 | MP0001984_abnormal_olfaction | 1.06890412 |
| 83 | MP0000747_muscle_weakness | 1.06481052 |
| 84 | MP0000955_abnormal_spinal_cord | 1.05192567 |
| 85 | MP0000569_abnormal_digit_pigmentation | 1.04967981 |
| 86 | MP0003436_decreased_susceptibility_to | 1.04567299 |
| 87 | MP0001905_abnormal_dopamine_level | 1.04264812 |
| 88 | MP0001177_atelectasis | 1.03905672 |
| 89 | MP0005330_cardiomyopathy | 1.03713965 |
| 90 | MP0003633_abnormal_nervous_system | 1.02372366 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 1.02214552 |
| 92 | MP0001348_abnormal_lacrimal_gland | 1.00750126 |
| 93 | MP0002229_neurodegeneration | 0.99955099 |
| 94 | MP0003075_altered_response_to | 0.97450431 |
| 95 | MP0006138_congestive_heart_failure | 0.97300589 |
| 96 | MP0002090_abnormal_vision | 0.96907978 |
| 97 | MP0000462_abnormal_digestive_system | 0.96199631 |
| 98 | MP0003878_abnormal_ear_physiology | 0.96065661 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.96065661 |
| 100 | MP0003631_nervous_system_phenotype | 0.95306974 |
| 101 | MP0004858_abnormal_nervous_system | 0.95236092 |
| 102 | MP0004130_abnormal_muscle_cell | 0.95069361 |
| 103 | MP0004142_abnormal_muscle_tone | 0.93470391 |
| 104 | MP0001963_abnormal_hearing_physiology | 0.92861368 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.92739326 |
| 106 | MP0004087_abnormal_muscle_fiber | 0.91638799 |
| 107 | MP0001533_abnormal_skeleton_physiology | 0.91250746 |
| 108 | MP0003303_peritoneal_inflammation | 0.90802099 |
| 109 | MP0008469_abnormal_protein_level | 0.89461140 |
| 110 | MP0004924_abnormal_behavior | 0.88758089 |
| 111 | MP0005386_behavior/neurological_phenoty | 0.88758089 |
| 112 | MP0010630_abnormal_cardiac_muscle | 0.88742649 |
| 113 | MP0002972_abnormal_cardiac_muscle | 0.88080176 |
| 114 | MP0005408_hypopigmentation | 0.87957299 |
| 115 | MP0002249_abnormal_larynx_morphology | 0.87851772 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.85151425 |
| 117 | MP0000749_muscle_degeneration | 0.85002518 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.84559293 |
| 119 | MP0002064_seizures | 0.84293029 |
| 120 | MP0001485_abnormal_pinna_reflex | 0.83985732 |
| 121 | MP0004484_altered_response_of | 0.82544471 |
| 122 | MP0003787_abnormal_imprinting | 0.81212614 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.80264594 |
| 124 | MP0003186_abnormal_redox_activity | 0.79957494 |
| 125 | MP0009763_increased_sensitivity_to | 0.79800470 |
| 126 | MP0004085_abnormal_heartbeat | 0.79084137 |
| 127 | MP0004885_abnormal_endolymph | 0.79044092 |
| 128 | MP0002152_abnormal_brain_morphology | 0.78476920 |
| 129 | MP0005171_absent_coat_pigmentation | 0.77791672 |
| 130 | MP0005174_abnormal_tail_pigmentation | 0.77534849 |
| 131 | MP0009764_decreased_sensitivity_to | 0.76609240 |
| 132 | MP0001346_abnormal_lacrimal_gland | 0.75404828 |
| 133 | MP0002822_catalepsy | 0.74384915 |
| 134 | MP0002269_muscular_atrophy | 0.73911245 |
| 135 | MP0005165_increased_susceptibility_to | 0.72414908 |
| 136 | MP0005409_darkened_coat_color | 0.71504258 |
| 137 | MP0001529_abnormal_vocalization | 0.71262828 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.70626187 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.69490361 |
| 140 | MP0001849_ear_inflammation | 0.68951669 |
| 141 | MP0003011_delayed_dark_adaptation | 0.68677267 |
| 142 | MP0005310_abnormal_salivary_gland | 0.68645660 |
| 143 | MP0001958_emphysema | 0.67833413 |
| 144 | MP0005166_decreased_susceptibility_to | 0.67383700 |
| 145 | MP0000598_abnormal_liver_morphology | 0.65912255 |
| 146 | MP0002909_abnormal_adrenal_gland | 0.65773311 |
| 147 | MP0002998_abnormal_bone_remodeling | 0.64839990 |
| 148 | MP0004381_abnormal_hair_follicle | 0.64136036 |
| 149 | MP0001765_abnormal_ion_homeostasis | 0.63776408 |
| 150 | MP0002184_abnormal_innervation | 0.62430384 |
| 151 | MP0004134_abnormal_chest_morphology | 0.62062295 |
| 152 | MP0001851_eye_inflammation | 0.61551373 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.60931492 |
| 154 | MP0008873_increased_physiological_sensi | 0.60868880 |
| 155 | MP0001764_abnormal_homeostasis | 0.59623609 |
| 156 | MP0001756_abnormal_urination | 0.59199613 |
| 157 | MP0008874_decreased_physiological_sensi | 0.59018000 |
| 158 | MP0005636_abnormal_mineral_homeostasis | 0.58894639 |
| 159 | MP0004270_analgesia | 0.58645359 |
| 160 | MP0009642_abnormal_blood_homeostasis | 0.58227763 |
| 161 | MP0005025_abnormal_response_to | 0.57915653 |
| 162 | MP0000003_abnormal_adipose_tissue | 0.56798021 |
| 163 | MP0002168_other_aberrant_phenotype | 0.55623479 |
| 164 | MP0002136_abnormal_kidney_physiology | 0.55578107 |
| 165 | MP0004947_skin_inflammation | 0.55443754 |
| 166 | MP0003638_abnormal_response/metabolism_ | 0.54122730 |
| 167 | MP0008260_abnormal_autophagy | 0.53472359 |
| 168 | MP0005164_abnormal_response_to | 0.53343982 |
| 169 | MP0000383_abnormal_hair_follicle | 0.53209526 |
| 170 | MP0001486_abnormal_startle_reflex | 0.53203123 |
| 171 | MP0001440_abnormal_grooming_behavior | 0.52973983 |
| 172 | MP0005448_abnormal_energy_balance | 0.52078592 |
| 173 | MP0005535_abnormal_body_temperature | 0.51724645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.46772001 |
| 2 | Axonal loss (HP:0003447) | 4.78488506 |
| 3 | Neurofibrillary tangles (HP:0002185) | 4.59812116 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.45516123 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.40956531 |
| 6 | Ankle clonus (HP:0011448) | 4.33406968 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.24870638 |
| 8 | Bundle branch block (HP:0011710) | 4.23015814 |
| 9 | Xanthomatosis (HP:0000991) | 4.18686676 |
| 10 | Action tremor (HP:0002345) | 4.18002013 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.06721445 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.96327135 |
| 13 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.82783052 |
| 14 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.82783052 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.79016381 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.77621590 |
| 17 | Sudden death (HP:0001699) | 3.76489936 |
| 18 | Focal motor seizures (HP:0011153) | 3.68059076 |
| 19 | Cerebral inclusion bodies (HP:0100314) | 3.62631999 |
| 20 | Diplopia (HP:0000651) | 3.55485224 |
| 21 | Abnormality of binocular vision (HP:0011514) | 3.55485224 |
| 22 | Obstructive sleep apnea (HP:0002870) | 3.52183656 |
| 23 | Focal seizures (HP:0007359) | 3.35032649 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.32573023 |
| 25 | Deep venous thrombosis (HP:0002625) | 3.29661135 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.22212677 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.19872129 |
| 28 | Heart block (HP:0012722) | 3.18270123 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.11029586 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.02750323 |
| 31 | Abnormality of the corticospinal tract (HP:0002492) | 3.02137440 |
| 32 | Peripheral demyelination (HP:0011096) | 3.01764898 |
| 33 | Scanning speech (HP:0002168) | 2.99519425 |
| 34 | Epileptic encephalopathy (HP:0200134) | 2.96049609 |
| 35 | Dysmetria (HP:0001310) | 2.95118143 |
| 36 | Syncope (HP:0001279) | 2.92501170 |
| 37 | Right ventricular cardiomyopathy (HP:0011663) | 2.89012933 |
| 38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87519836 |
| 39 | Atrioventricular block (HP:0001678) | 2.87515811 |
| 40 | Amyloidosis (HP:0011034) | 2.86138587 |
| 41 | Fat malabsorption (HP:0002630) | 2.83307717 |
| 42 | Loss of speech (HP:0002371) | 2.82740066 |
| 43 | Ventricular fibrillation (HP:0001663) | 2.80054172 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79728475 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.77829764 |
| 46 | Onion bulb formation (HP:0003383) | 2.77279267 |
| 47 | Febrile seizures (HP:0002373) | 2.73357233 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.71978883 |
| 49 | Visual hallucinations (HP:0002367) | 2.67726744 |
| 50 | Ileus (HP:0002595) | 2.65022647 |
| 51 | Hepatosplenomegaly (HP:0001433) | 2.63965147 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.60532328 |
| 53 | Intention tremor (HP:0002080) | 2.60095231 |
| 54 | Atonic seizures (HP:0010819) | 2.56031291 |
| 55 | Hypobetalipoproteinemia (HP:0003563) | 2.55736793 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.54433524 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.54433524 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.54433524 |
| 59 | Joint hemorrhage (HP:0005261) | 2.54212777 |
| 60 | Parakeratosis (HP:0001036) | 2.53414319 |
| 61 | Postural instability (HP:0002172) | 2.52556767 |
| 62 | Atrial fibrillation (HP:0005110) | 2.52053144 |
| 63 | Alacrima (HP:0000522) | 2.52013566 |
| 64 | Turricephaly (HP:0000262) | 2.49890939 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.49881682 |
| 66 | Ventricular arrhythmia (HP:0004308) | 2.49454492 |
| 67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.48673536 |
| 68 | Annular pancreas (HP:0001734) | 2.46771397 |
| 69 | Epidermoid cyst (HP:0200040) | 2.46429697 |
| 70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46277390 |
| 71 | Bronchomalacia (HP:0002780) | 2.45708442 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42540313 |
| 73 | Mucopolysacchariduria (HP:0008155) | 2.42540313 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 2.41508239 |
| 75 | Paraparesis (HP:0002385) | 2.41371957 |
| 76 | Steatorrhea (HP:0002570) | 2.40915275 |
| 77 | Insomnia (HP:0100785) | 2.40478536 |
| 78 | Prolonged partial thromboplastin time (HP:0003645) | 2.40269297 |
| 79 | Complement deficiency (HP:0004431) | 2.39767055 |
| 80 | Distal lower limb muscle weakness (HP:0009053) | 2.39572847 |
| 81 | Aplasia involving bones of the extremities (HP:0009825) | 2.39035566 |
| 82 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.39035566 |
| 83 | Aplasia of the phalanges of the hand (HP:0009802) | 2.39035566 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 2.38499970 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.36880246 |
| 86 | Cholecystitis (HP:0001082) | 2.36880246 |
| 87 | Protuberant abdomen (HP:0001538) | 2.36208387 |
| 88 | Vascular calcification (HP:0004934) | 2.36072291 |
| 89 | Abnormality of the foot musculature (HP:0001436) | 2.35297888 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34912135 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34912135 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34912135 |
| 93 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.33754664 |
| 94 | Primary atrial arrhythmia (HP:0001692) | 2.33098724 |
| 95 | Torticollis (HP:0000473) | 2.31425774 |
| 96 | Upper limb amyotrophy (HP:0009129) | 2.31424007 |
| 97 | Distal upper limb amyotrophy (HP:0007149) | 2.31424007 |
| 98 | Abnormality of methionine metabolism (HP:0010901) | 2.31323864 |
| 99 | Ventricular tachycardia (HP:0004756) | 2.28617176 |
| 100 | Spastic tetraparesis (HP:0001285) | 2.28398739 |
| 101 | Myocardial infarction (HP:0001658) | 2.27978386 |
| 102 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.27142729 |
| 103 | Increased circulating renin level (HP:0000848) | 2.25223392 |
| 104 | Clumsiness (HP:0002312) | 2.24501156 |
| 105 | Clonus (HP:0002169) | 2.24263345 |
| 106 | Supraventricular tachycardia (HP:0004755) | 2.24138586 |
| 107 | Generalized tonic-clonic seizures (HP:0002069) | 2.23843226 |
| 108 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23730428 |
| 109 | Peripheral hypomyelination (HP:0007182) | 2.22198655 |
| 110 | Tetraplegia (HP:0002445) | 2.22088833 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21232707 |
| 112 | Abnormality of the salivary glands (HP:0010286) | 2.20274177 |
| 113 | Depression (HP:0000716) | 2.19098781 |
| 114 | Abnormal eating behavior (HP:0100738) | 2.18997339 |
| 115 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18821373 |
| 116 | Abnormality of the Achilles tendon (HP:0005109) | 2.18636103 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 2.17857135 |
| 118 | Supraventricular arrhythmia (HP:0005115) | 2.16763001 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 2.16352007 |
| 120 | Ketosis (HP:0001946) | 2.16206800 |
| 121 | Rapidly progressive (HP:0003678) | 2.15350569 |
| 122 | Abnormality of glycine metabolism (HP:0010895) | 2.15283726 |
| 123 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15283726 |
| 124 | Lower limb amyotrophy (HP:0007210) | 2.15019639 |
| 125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.14632980 |
| 126 | Truncal ataxia (HP:0002078) | 2.13092633 |
| 127 | Cerebral aneurysm (HP:0004944) | 2.11864484 |
| 128 | Lower limb muscle weakness (HP:0007340) | 2.11784359 |
| 129 | Hypophosphatemic rickets (HP:0004912) | 2.09650041 |
| 130 | Cerebral hemorrhage (HP:0001342) | 2.07926962 |
| 131 | Increased serum ferritin (HP:0003281) | 2.07557505 |
| 132 | Rigidity (HP:0002063) | 2.07251845 |
| 133 | Hydroxyprolinuria (HP:0003080) | 2.03583467 |
| 134 | Abnormality of proline metabolism (HP:0010907) | 2.03583467 |
| 135 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.03518548 |
| 136 | Recurrent bacterial skin infections (HP:0005406) | 2.03154870 |
| 137 | Skin nodule (HP:0200036) | 2.02953411 |
| 138 | Hyperammonemia (HP:0001987) | 2.02777766 |
| 139 | Abnormality of vision evoked potentials (HP:0000649) | 2.02301467 |
| 140 | Urinary urgency (HP:0000012) | 2.02145102 |
| 141 | Abnormal auditory evoked potentials (HP:0006958) | 2.01496499 |
| 142 | Cardiovascular calcification (HP:0011915) | 2.00118176 |
| 143 | Abnormality of the periventricular white matter (HP:0002518) | 1.99468671 |
| 144 | Abnormality of the intrinsic pathway (HP:0010989) | 1.99252091 |
| 145 | Spastic paraparesis (HP:0002313) | 1.98717451 |
| 146 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.98102558 |
| 147 | Cholelithiasis (HP:0001081) | 1.97909302 |
| 148 | Morphological abnormality of the inner ear (HP:0011390) | 1.97810431 |
| 149 | Pathologic fracture (HP:0002756) | 1.96110858 |
| 150 | Achilles tendon contracture (HP:0001771) | 1.95446349 |
| 151 | EMG: neuropathic changes (HP:0003445) | 1.93211813 |
| 152 | Hypolipoproteinemia (HP:0010981) | 1.91817730 |
| 153 | Sudden cardiac death (HP:0001645) | 1.91812725 |
| 154 | Dysdiadochokinesis (HP:0002075) | 1.91726829 |
| 155 | Status epilepticus (HP:0002133) | 1.90958570 |
| 156 | Dysmetric saccades (HP:0000641) | 1.90843348 |
| 157 | Cerebral hypomyelination (HP:0006808) | 1.90341854 |
| 158 | Sleep apnea (HP:0010535) | 1.90325280 |
| 159 | Sensory axonal neuropathy (HP:0003390) | 1.89913043 |
| 160 | Abnormality of the lower motor neuron (HP:0002366) | 1.88738180 |
| 161 | Anxiety (HP:0000739) | 1.88700686 |
| 162 | Termporal pattern (HP:0011008) | 1.87625781 |
| 163 | Insidious onset (HP:0003587) | 1.87625781 |
| 164 | Akinesia (HP:0002304) | 1.86841662 |
| 165 | Global brain atrophy (HP:0002283) | 1.86172477 |
| 166 | Spastic gait (HP:0002064) | 1.86141924 |
| 167 | Hemiplegia (HP:0002301) | 1.85948907 |
| 168 | Increased serum pyruvate (HP:0003542) | 1.84953294 |
| 169 | Abnormality of glycolysis (HP:0004366) | 1.84953294 |
| 170 | Distal sensory impairment (HP:0002936) | 1.84483906 |
| 171 | Progressive cerebellar ataxia (HP:0002073) | 1.84371446 |
| 172 | Stridor (HP:0010307) | 1.84160926 |
| 173 | Prolonged QT interval (HP:0001657) | 1.83635946 |
| 174 | Partial duplication of thumb phalanx (HP:0009944) | 1.82212284 |
| 175 | Hyperacusis (HP:0010780) | 1.81026091 |
| 176 | Mutism (HP:0002300) | 1.80064818 |
| 177 | Choreoathetosis (HP:0001266) | 1.79373676 |
| 178 | Shallow orbits (HP:0000586) | 1.79362126 |
| 179 | Hand muscle atrophy (HP:0009130) | 1.78895790 |
| 180 | Apathy (HP:0000741) | 1.77959674 |
| 181 | Abnormal EKG (HP:0003115) | 1.76409624 |
| 182 | Hammertoe (HP:0001765) | 1.76333377 |
| 183 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75832602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.68754385 |
| 2 | EPHB1 | 4.40495990 |
| 3 | EPHA4 | 3.76206128 |
| 4 | RIPK1 | 3.29545859 |
| 5 | NTRK3 | 3.27894016 |
| 6 | OXSR1 | 3.16816434 |
| 7 | MAPKAPK5 | 3.10061085 |
| 8 | PBK | 2.68503957 |
| 9 | PRKD3 | 2.66113192 |
| 10 | MARK1 | 2.62799737 |
| 11 | ERN1 | 2.54882651 |
| 12 | DAPK2 | 2.52561922 |
| 13 | BCKDK | 2.43314086 |
| 14 | WNK4 | 2.24211788 |
| 15 | NTRK2 | 2.22584404 |
| 16 | TAOK3 | 2.22147025 |
| 17 | PKN1 | 2.14635443 |
| 18 | MET | 2.05996448 |
| 19 | TRIB3 | 2.05143441 |
| 20 | PRPF4B | 1.80361890 |
| 21 | MAP3K9 | 1.73527986 |
| 22 | CAMKK1 | 1.70767844 |
| 23 | NTRK1 | 1.69991336 |
| 24 | FGFR4 | 1.58858166 |
| 25 | FGR | 1.55117736 |
| 26 | BMX | 1.54460094 |
| 27 | PTK6 | 1.46802071 |
| 28 | WNK1 | 1.44799081 |
| 29 | MINK1 | 1.42882170 |
| 30 | LATS2 | 1.37750759 |
| 31 | LMTK2 | 1.35754473 |
| 32 | KIT | 1.34489221 |
| 33 | TESK2 | 1.29851064 |
| 34 | GSK3A | 1.29600368 |
| 35 | TBK1 | 1.27367002 |
| 36 | SIK1 | 1.26173886 |
| 37 | NEK6 | 1.25072966 |
| 38 | MAP2K2 | 1.21977662 |
| 39 | ARAF | 1.21054314 |
| 40 | CAMK1 | 1.19470825 |
| 41 | DMPK | 1.14773167 |
| 42 | MST4 | 1.13850030 |
| 43 | ABL2 | 1.12120194 |
| 44 | PDPK1 | 1.12047492 |
| 45 | MAP3K2 | 1.11712222 |
| 46 | PHKG2 | 1.08979321 |
| 47 | PHKG1 | 1.08979321 |
| 48 | PTK2 | 1.08753774 |
| 49 | TTN | 1.08123758 |
| 50 | CAMK2D | 1.07453828 |
| 51 | IRAK4 | 1.06230281 |
| 52 | CSNK1G3 | 1.05961835 |
| 53 | SGK223 | 1.05945783 |
| 54 | SGK494 | 1.05945783 |
| 55 | FES | 1.04988556 |
| 56 | MST1R | 1.03609225 |
| 57 | CSF1R | 1.01416130 |
| 58 | PRKG2 | 1.01350489 |
| 59 | UHMK1 | 1.01335134 |
| 60 | GRK5 | 1.00326605 |
| 61 | PDGFRA | 1.00141509 |
| 62 | ICK | 0.98989622 |
| 63 | SMG1 | 0.98182213 |
| 64 | EEF2K | 0.97224297 |
| 65 | MOS | 0.95893012 |
| 66 | PRKD1 | 0.94653774 |
| 67 | STK38 | 0.94589542 |
| 68 | DAPK1 | 0.92891686 |
| 69 | EPHA2 | 0.92094929 |
| 70 | SGK3 | 0.91359778 |
| 71 | SIK2 | 0.91265376 |
| 72 | MAP3K11 | 0.89372098 |
| 73 | ERBB4 | 0.88984098 |
| 74 | MAP3K13 | 0.88404303 |
| 75 | ROCK2 | 0.87688069 |
| 76 | IRAK3 | 0.87645492 |
| 77 | BLK | 0.86736989 |
| 78 | MAPK10 | 0.86354179 |
| 79 | MYLK | 0.84635756 |
| 80 | IRAK2 | 0.83949212 |
| 81 | CSNK1A1L | 0.83373927 |
| 82 | CSNK1G2 | 0.82633641 |
| 83 | CSK | 0.82499283 |
| 84 | CAMK2B | 0.82016398 |
| 85 | TYRO3 | 0.81134513 |
| 86 | PRKCQ | 0.79865350 |
| 87 | CDK15 | 0.78773989 |
| 88 | PIK3CG | 0.78623506 |
| 89 | CSNK1G1 | 0.77989698 |
| 90 | SGK2 | 0.77725824 |
| 91 | CAMK1G | 0.76590176 |
| 92 | FGFR3 | 0.74391687 |
| 93 | CDK18 | 0.72364950 |
| 94 | MAP3K7 | 0.72317572 |
| 95 | CDK11A | 0.72191349 |
| 96 | CAMK2G | 0.71632994 |
| 97 | MUSK | 0.70457583 |
| 98 | SGK1 | 0.69546463 |
| 99 | RIPK4 | 0.68901204 |
| 100 | FYN | 0.65952955 |
| 101 | CAMK4 | 0.65844166 |
| 102 | STK11 | 0.65630454 |
| 103 | RET | 0.65525407 |
| 104 | GRK7 | 0.65420755 |
| 105 | PAK6 | 0.65261609 |
| 106 | CDC42BPA | 0.64738061 |
| 107 | MAP3K1 | 0.64298512 |
| 108 | HCK | 0.64097102 |
| 109 | DDR2 | 0.62908056 |
| 110 | PLK2 | 0.62864542 |
| 111 | ROCK1 | 0.62831199 |
| 112 | CAMK1D | 0.62012612 |
| 113 | PAK3 | 0.61739858 |
| 114 | PDK1 | 0.60448625 |
| 115 | PAK2 | 0.59301020 |
| 116 | TESK1 | 0.58843776 |
| 117 | EGFR | 0.58560971 |
| 118 | RPS6KA3 | 0.58109348 |
| 119 | CDK14 | 0.57066024 |
| 120 | PKN2 | 0.56828892 |
| 121 | DYRK1A | 0.56281512 |
| 122 | PRKCG | 0.54168347 |
| 123 | ABL1 | 0.52896840 |
| 124 | BCR | 0.51650016 |
| 125 | FGFR2 | 0.51521570 |
| 126 | TGFBR2 | 0.51450316 |
| 127 | PDGFRB | 0.51034487 |
| 128 | CAMK2A | 0.50288190 |
| 129 | KSR2 | 0.49594653 |
| 130 | DAPK3 | 0.49402949 |
| 131 | PIK3CA | 0.49365081 |
| 132 | MAP2K6 | 0.48674023 |
| 133 | TNK2 | 0.48349952 |
| 134 | TRPM7 | 0.47318587 |
| 135 | SRC | 0.46866969 |
| 136 | MTOR | 0.46089942 |
| 137 | LIMK1 | 0.45827078 |
| 138 | PRKCE | 0.45467295 |
| 139 | MARK2 | 0.44526615 |
| 140 | PRKCH | 0.42542325 |
| 141 | PRKG1 | 0.42472147 |
| 142 | CDK5 | 0.42266718 |
| 143 | ERBB2 | 0.42046107 |
| 144 | PRKCZ | 0.41893076 |
| 145 | MAPK12 | 0.41714597 |
| 146 | JAK2 | 0.40565700 |
| 147 | TYK2 | 0.40515735 |
| 148 | JAK1 | 0.40349627 |
| 149 | INSR | 0.40119913 |
| 150 | PRKACB | 0.39709597 |
| 151 | ALK | 0.38388856 |
| 152 | GRK6 | 0.37884691 |
| 153 | PINK1 | 0.37372124 |
| 154 | CSNK1A1 | 0.37248790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.76712150 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17582433 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72741419 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.68643464 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.67040850 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.63028079 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.61642099 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.44914144 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.21104581 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19700199 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.16599674 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.03822276 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00951286 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97345074 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.94784562 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.94613037 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90924473 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.88935739 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87343721 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.86905595 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86418484 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.81103199 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.80884772 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.77987097 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.73358480 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72775215 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.71058433 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.70827465 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68571620 |
| 30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.65794628 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61157674 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58274427 |
| 33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57927289 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57141422 |
| 35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54739692 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53779843 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.49406167 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48610074 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46615719 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46509779 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.43818654 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43459620 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.41488930 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.40689611 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.39819241 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.39731520 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.38719183 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37764345 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37601719 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35806991 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35780479 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.35056449 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33922653 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33671814 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 1.32273575 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 1.31275370 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25960999 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25873574 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24403129 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20957478 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18640314 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.18287576 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17377713 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16396807 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 1.14367257 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13644834 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13353087 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11283997 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.10993790 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.10195786 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08845675 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08720491 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06475425 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06424302 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05751632 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01494916 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 1.01188235 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00915099 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00643159 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97674204 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97398083 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97221280 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95828335 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95230060 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94137997 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90657753 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.90323999 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90067389 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89291308 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87849808 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86633799 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.86058582 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.85176269 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.84138068 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80586273 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79428971 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79358970 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78048514 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77718596 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76753746 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75996424 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.75653335 |
| 103 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75499044 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75269820 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74264000 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.68710775 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68710284 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68352548 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67065853 |
| 110 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66212412 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64480926 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63394274 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62111504 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62040413 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60793357 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.60670520 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59939151 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59889423 |
| 119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59561783 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59280786 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59224645 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59101679 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59043802 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57726233 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.57650635 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56856375 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56396511 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56169961 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55176388 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53191039 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53061192 |
| 132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52228994 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51298075 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50019989 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46112238 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45937209 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.44702024 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43792115 |
| 139 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43728362 |
| 140 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42786008 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41950729 |
| 142 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41610051 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41073279 |
| 144 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40684075 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39642931 |
| 146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39605767 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36677007 |
| 148 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32623144 |
| 149 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32077396 |
| 150 | Protein export_Homo sapiens_hsa03060 | 0.29639830 |
| 151 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29351667 |
| 152 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28010060 |
| 153 | Lysine degradation_Homo sapiens_hsa00310 | 0.26401107 |
| 154 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26213601 |
| 155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25920635 |
| 156 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.25025605 |
| 157 | Hepatitis C_Homo sapiens_hsa05160 | 0.23798999 |
| 158 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22868004 |
| 159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22735538 |
| 160 | Endocytosis_Homo sapiens_hsa04144 | 0.20938715 |
| 161 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.19894642 |
| 162 | Malaria_Homo sapiens_hsa05144 | 0.19783953 |
| 163 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19616784 |
| 164 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19187174 |
| 165 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.19084900 |
| 166 | Amoebiasis_Homo sapiens_hsa05146 | 0.18694630 |
| 167 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18289321 |

